CN102319400B - Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof - Google Patents

Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof Download PDF

Info

Publication number
CN102319400B
CN102319400B CN2011102887105A CN201110288710A CN102319400B CN 102319400 B CN102319400 B CN 102319400B CN 2011102887105 A CN2011102887105 A CN 2011102887105A CN 201110288710 A CN201110288710 A CN 201110288710A CN 102319400 B CN102319400 B CN 102319400B
Authority
CN
China
Prior art keywords
radix
add
ethanol
fine powder
pollen typhae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2011102887105A
Other languages
Chinese (zh)
Other versions
CN102319400A (en
Inventor
黄小华
付彬
石丽
张�浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEILIN PHARMACEUTICAL Co Ltd XI'AN
Original Assignee
BEILIN PHARMACEUTICAL Co Ltd XI'AN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEILIN PHARMACEUTICAL Co Ltd XI'AN filed Critical BEILIN PHARMACEUTICAL Co Ltd XI'AN
Priority to CN2011102887105A priority Critical patent/CN102319400B/en
Publication of CN102319400A publication Critical patent/CN102319400A/en
Application granted granted Critical
Publication of CN102319400B publication Critical patent/CN102319400B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and a preparation method thereof. The traditional Chinese drug composition is prepared from the following nineteen traditional Chinese drugs: cattail pollen, salvia miltiorrhiza, rehmannia, eclipta, chrysanthemum, baikal skullcap root (charred radix scutellariae), obtuseleaf senna seed, asiatic plantain seed, common motherwort fruit, glossy privet fruit, common selfheal spike, Chinese gentian root, wenchow turmeric root tuber, common scouring rush, red peony root, tree peony root-bark, hawthorn, angelica and szechwan lovage rhizome. The traditional Chinese drug composition has effects of blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and is mainly applicable for yin deficiency, liver hyperactivity, and subhyaloid hemorrhage caused by collateral thermal injury. Compared to the prior art, the clinical pharmacodynamics test effects of the traditional Chinese drug composition provided by the present invention are significantly increased, the bioavailability of the traditional Chinese drug composition provided by the present invention is high, and the traditional Chinese drug composition provided by the present invention does not cause any toxic and side-effect.

Description

A kind of Chinese medicine composition that is used for cooling blood for hemostasis, YIN nourishing blood stasis dispelling, nourishing the liver to improve visual acuity and preparation method thereof
Technical field
The present invention relates to a kind of Chinese medicine composition that is used for cooling blood for hemostasis, YIN nourishing blood stasis dispelling, nourishing the liver to improve visual acuity and preparation method thereof, belong to the pharmaceutical technology field.
Technical background
The eyes pathological changes of bringing out along with factor such as the increase of the pollution of environment, life stress, the tired anxiety of people's spirit in recent years is more and more, has seriously influenced daily life, has brought great misery to people.The medicine that uses clinically at present is a lot, but curative effect is undesirable mostly." and XUEMINGMU PIAN " under WS-10062 (ZD-0062)-2002 in " the national standard for traditional Chinese medicines compilation ophthalmology department of otorhinolaryngology department of dermatologry fascicle " of State Food and Drug Administration's in December, 2002 promulgation discloses its prescription and method for making; The inventor is through years of researches; Find that the preparation that makes with its technology exists: curative effect is desirable not enough; Technology is thicker, and poor stability is prone to defectives such as the moisture absorption goes bad.
For solving above-mentioned existing in prior technology defective, in the time in recent years, we are through excavating the abundant Chinese medicine resource of motherland; In conjunction with the lots of clinical pharmacodynamic study, we grope through a large amount of experiments on the basis of original and XUEMINGMU PIAN technology; Discovery with the water in its technology carry make into 6 times the amount 60% ethanol extractions after, extraction ratio of effective constituents significantly improves, its clinical pharmacodynamic experiment effect significantly improves; Good stability, and safe without toxic side effect; We have processed tablet, capsule, granule, soft capsule or drop pill by common process; Most preferred dosage form is a tablet.
Summary of the invention
The objective of the invention is to: Chinese medicine composition that a kind of curative effect is used for cooling blood for hemostasis, YIN nourishing blood stasis dispelling, nourishing the liver to improve visual acuity more significantly and preparation method thereof is provided.
Chinese medicine composition of the present invention, its prescription is formed as follows:
Figure BSA00000581455000011
Method for preparing is: above 19 flavor medical materials, and Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; Filtrate decompression concentrates (0.08MPa; 80 ℃) be the thick paste of 1.35~1.39 (60 ℃) to relative density; Add above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry are ground into fine powder; Add each dosage form proper auxiliary materials, process tablet, capsule, granule, soft capsule or drop pill by each dosage form common process.
1, the method for preparing of Chinese medicine composition tablet of the present invention is following:
Prescription:
Figure BSA00000581455000021
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry; Be ground into fine powder, add dextrin, process granule with 85% ethanol, 60 ℃ of oven dry; Granulate adds magnesium stearate, mixing; Be pressed into 1000, coating promptly gets tablet.
2, the method for preparing of Chinese medicinal composition capsules agent of the present invention is following:
Prescription:
Figure BSA00000581455000022
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry; Be ground into fine powder, add starch, process granule with 85% ethanol, 60 ℃ of oven dry; Granulate, promptly gets capsule by encapsulated 1000.
3, the method for preparing of Chinese medicinal composition granules of the present invention is following:
Prescription:
Figure BSA00000581455000031
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry; Be ground into fine powder, the adding dextrin is an amount of, processes granule with 85% ethanol, 60 ℃ of oven dry; Granulate makes granule 1000g, promptly gets granule.
4, Chinese medicine composition soft capsule method for preparing of the present invention is following:
Prescription:
Figure BSA00000581455000032
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, and 60 ℃ of oven dry are ground into fine powder, gets the hybrid medicine fine powder, subsequent use; It is an amount of to get the adjuvant soybean oil, adds the Cera Flava of 4-6%, after heating makes dissolving, adds above-mentioned hybrid medicine fine powder, stirs, and colloid mill grinds well, and processes 1000 of soft capsules, promptly gets soft capsule.
5, Chinese medicine composition drop pill method for preparing of the present invention is following:
Prescription:
Figure BSA00000581455000033
Figure BSA00000581455000041
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, and 60 ℃ of oven dry are ground into fine powder, gets the hybrid medicine fine powder, subsequent use; Macrogol 4000 put in the water-bath heat, melt the back and add above-mentioned hybrid medicine fine powder, stirring is transferred to reservoir, airtight and in 70 ℃ of insulations, is coolant with the methyl-silicone oil, processes drop pill, promptly gets drop pill.
Stability experiment
(1) experiment material:
1. medicine:
1. tablet group A of the present invention: the method preparation according to the embodiment of the invention 1, get tablet A, be assigned to desired concn with normal saline during experiment.
2. matched group B: just following with the concrete method for preparing of XUEMINGMU PIAN agent group:
Prescription:
Figure BSA00000581455000042
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors were soaked 30 minutes, the reflux, extract, secondary, and each 2 hours, collecting decoction filtered; Filtrate decompression is concentrated into the thick paste that relative density is 1.35~1.39 (60 ℃), adds above-mentioned fine powder mix homogeneously, and 60 ℃ of oven dry are ground into fine powder, adds dextrin 30g; Process granule with 85% ethanol, 60 ℃ of oven dry, granulate adds magnesium stearate 1.5g; Mixing, tabletting, sugar coating promptly gets tablet B.
2. animal: Japan large ear rabbit.
(2), method and result:
1, test method: above sample is positioned in 4-6 ℃, 20-25 ℃, 35-38 ℃ the calorstat, makes regular check on stability indicator according to time of repose, the criterion that its result observes is following:
0 does not have deposition 1 does not have muddy 2 little turbid 3 muddy 4 depositions
2. result of the test: result of the test is seen table 2
Table 2 stability test
Figure BSA00000581455000051
3. conclusion (of pressure testing): can know that through this result of the test tablet group A of the present invention does not have muddiness, deposition produces; Contrast tablet group B has muddiness, deposition to produce.
(3), brief summary: show through the study on the stability test: under identical condition, tablet group A of the present invention is more stable than comparison film agent group B.
The present invention program is through inventor's repetition test repeatedly, updates that adjustment sums up out, and the method for preparing of the invention described above tablet group is best method for preparing, and clinical pharmacodynamic experiment effect significantly improves.
With tablet of the present invention is example, and Pharmacodynamic test of active extract result proves: with the present invention " method for preparing: above 19 flavor medical materials, Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry; Be ground into fine powder, add dextrin, process granule with 85% ethanol, 60 ℃ of oven dry; Granulate adds magnesium stearate, mixing; Be pressed into 1000, coating promptly gets tablet of the present invention " with former invention " (and XUEMINGMU PIAN) method for preparing: above 19 flavor medical materials; Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors were soaked 30 minutes, the reflux, extract, secondary, and each 2 hours, collecting decoction filtered; Filtrate decompression is concentrated into the thick paste that relative density is 1.35~1.39 (60 ℃), adds above-mentioned fine powder mix homogeneously, and 60 ℃ of oven dry are ground into fine powder; Add dextrin 30g, process granulation with 85% ethanol, 60 ℃ of oven dry, granulate; Add magnesium stearate 1.5g, mixing, tabletting; Sugar coating promptly gets " to compare, results of pharmacodynamic test has significance to improve.
Pharmacodynamic test of active extract
One, the preparation of experiment medicine:
1, tablet group of the present invention:
Prescription:
Figure BSA00000581455000061
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry; Be ground into fine powder, add dextrin, process granule with 85% ethanol, 60 ℃ of oven dry; Granulate adds magnesium stearate, mixing; Be pressed into 1000, coating promptly gets.
1, positive controls (and XUEMINGMU PIAN):
Prescription:
Figure BSA00000581455000062
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors were soaked 30 minutes, the reflux, extract, secondary, and each 2 hours, collecting decoction filtered; Filtrate decompression is concentrated into the thick paste that relative density is 1.35~1.39 (60 ℃), adds above-mentioned fine powder mix homogeneously, and 60 ℃ of oven dry are ground into fine powder, adds dextrin 30g; Process granule with 85% ethanol, 60 ℃ of oven dry, granulate adds magnesium stearate 1.5g; Mixing, tabletting, sugar coating promptly gets.
Two: process of the test and result of the test
Experiment purpose: through to sheet of the present invention and with pharmacological experiment studies such as the hemostasis of XUEMINGMU PIAN, blood coagulation, inhibition capillary permeability, microcirculation improvement, human body immunity improving power; Compare experiment with sheet group of the present invention with XUEMINGMU PIAN, observe the power of its pharmacological action.
Test method: sheet of the present invention and with the influence of XUEMINGMU PIAN to the mice docking bleeding time; Influence to the rat platelet number; Influence to the heparinization clotting time of mice; Influence to the multiple calcium clotting time of rabbit; To the phagocytotic influence of Turnover of Mouse Peritoneal Macrophages; Influence to the mice capillary permeability; To the microcirculatory influence of tame lagophthalmos conjunctiva; To effect of immunologic function.
Experimental result: sheet of the present invention and with XUEMINGMU PIAN can obviously shorten the mice bleeding time; The platelet count of rat obviously increases; Shorten the clotting time of experimental disorders of hemostasis animal; The multiple calcium clotting time of rabbit is obviously shortened; Obviously improve the phagocytic index of Turnover of Mouse Peritoneal Macrophages, promote the absorption of congestion; Suppressing the abdominal cavity capillary permeability increases, and stops hemocyte to ooze out and is beneficial to hemostasis; Promote the speed of tame lagophthalmos conjunctiva microcirculation blood flow; Obviously increase the content of hemolysin in the serum, improve humoral immune function.
Conclusion: pharmacological actions such as the hemostasis of sheet ratio of the present invention and XUEMINGMU PIAN, blood coagulation, inhibition capillary permeability, microcirculation improvement, human body immunity improving power are strong; Therefore; Sheet group ratio of the present invention and XUEMINGMU PIAN are used for deficiency of YIN liver-yang hyperactivity, and the caused retinal hemorrhage clinical efficacy of thermal burn channels is good.
One, to the mice influence in docking bleeding time
Experiment material
1, animal: Kunming mouse, male and female have concurrently, body weight 18~22g.
2, medicine: with XUEMINGMU PIAN 0.84g crude drug/sheet; Large, medium and small three the dose groups 0.84g crude drug/sheets of sheet of the present invention.Medicine disposes with distilled water before experiment, gastric infusion.
Experimental technique
50 of Kunming mouses, male and female half and half, body weight 18~22g is divided into 5 groups at random, 10 every group.Matched group is irritated the normal saline of stomach with volume; Sheet group of the present invention is gastric infusion 3.6,1.8,0.9g crude drug/kg respectively; With XUEMINGMU PIAN group gastric infusion 3.6g crude drug/kg.Successive administration 7d, every day 1 time, each 20ml/kg.Behind the last administration 30min, it is cross-section respectively each to be organized Mus back range tail point 5mm place, treats that blood overflows the back voluntarily and picks up counting with stopwatch, and every dehematizing with the filter paper suction at a distance from 30s dripped 1 time.Overflow and pick up counting with Mus tail section blood, the mice bleeding time respectively organized in record as the bleeding time depletion of blood time when inhaling section with filter paper.
Experimental result: see table 1
The influence
Figure BSA00000581455000071
in table 1 pair mice docking bleeding time
Figure BSA00000581455000072
Figure BSA00000581455000081
Compare * * P<0.01 with matched group; With with the XUEMINGMU PIAN group than △ P<0.05.
The result shows: sheet group of the present invention and with the XUEMINGMU PIAN group can obviously shorten the mice bleeding time, compared utmost point significant difference (P<0.01) with matched group; The heavy dose of group of sheet of the present invention with and the XUEMINGMU PIAN group significant difference (P<0.05) of having compared.It is thus clear that the anastalsis of sheet group ratio of the present invention and XUEMINGMU PIAN group is strong.
Two, to the influence of rat platelet number
Experiment material
1, animal: the SD rat, male and female have concurrently, body weight 180~220g.
2, medicine: with XUEMINGMU PIAN 0.84g crude drug/sheet; Large, medium and small three the dose groups 0.84g crude drug/sheets of sheet of the present invention.Medicine disposes with distilled water before experiment, gastric infusion.
Experimental technique
50 of SD rats, male and female half and half, body weight 180~220g is divided into 5 groups at random, 10 every group.Matched group is irritated the normal saline of stomach with volume; Sheet group of the present invention is gastric infusion 2.4,1.2,0.6g crude drug/kg respectively; With XUEMINGMU PIAN group gastric infusion 2.4g crude drug/kg.Successive administration 7d, every day 1 time, 2h gets blood system platelet rich plasma after the last administration, with microscopy method direct count platelet count.
Experimental result: see table 2
The influence of table 2 pair rat platelet number
Figure BSA00000581455000082
Compare * * P<0.01 with matched group; With with the XUEMINGMU PIAN group than △ P<0.05.
The result shows: sheet group of the present invention and can obviously increase the platelet count of rat with the XUEMINGMU PIAN group, compared utmost point significant difference (P<0.01) with matched group; The heavy dose of group of sheet of the present invention with and the XUEMINGMU PIAN group significant difference (P<0.05) of having compared.It is thus clear that sheet group ratio of the present invention and XUEMINGMU PIAN group anastalsis are strong.
Three, to the influence of heparinization clotting time of mice
Experiment material
1, animal: Kunming mouse, male and female have concurrently, body weight 18~22g.
2, medicine: with XUEMINGMU PIAN 0.84g crude drug/sheet; Large, medium and small three the dose groups 0.84g crude drug/sheets of sheet of the present invention.Medicine disposes with distilled water before experiment, gastric infusion.
Experimental technique
60 of Kunming mouses, male and female half and half, body weight 18~22g is divided into 6 groups at random, 10 every group.Blank group and model group are irritated the normal saline of stomach with volume; Sheet group of the present invention is gastric infusion 3.6,1.8,0.9g crude drug/kg respectively; With XUEMINGMU PIAN group gastric infusion 3.6g crude drug/kg.Successive administration 7d, every day 1 time, each 20ml/kg, 15min before the last administration, except that the blank group, each organizes mice tail vein injection 7u/ml heparin-saline 0.1ml/10g modeling respectively.Each organizes 30min behind the mice last gastric infusion; Extract eyeball blood sampling 0.5ml; Splash in the test tube of long 10cm, internal diameter 9mm (37 ℃ of constant temperature water baths); Whether whenever subsequently observe blood and flow at a distance from slowly tilt test tube 30 degree 1 time of 30s, the record autoblood splashes into test tube and rises to test tube to tilt for 90 immobilising times of blood (clotting time) when spending.
Experimental result: see table 3
The influence of table 3 pair clotting time of mice
Figure BSA00000581455000091
Figure BSA00000581455000092
Compare * * P<0.01 with model group; With with the XUEMINGMU PIAN group than △ P<0.05.
The result shows: sheet group of the present invention and have the clotting time effect of shortening experimental disorders of hemostasis animal with the XUEMINGMU PIAN group, compared utmost point significant difference (P<0.01) with model group; The heavy dose of group of sheet of the present invention with and the XUEMINGMU PIAN group significant difference (P<0.05) of having compared.It is thus clear that sheet group ratio of the present invention and XUEMINGMU PIAN group Blood clotting are strong.
Four, to the rabbit influence of calcium clotting time again
Experiment material
1, animal: rabbit, male and female have concurrently, body weight 1.8~2.2kg.
2, medicine: with XUEMINGMU PIAN 0.84g crude drug/sheet; Large, medium and small three the dose groups 0.84g crude drug/sheets of sheet of the present invention.Medicine disposes with distilled water before experiment, gastric infusion.
Experimental technique
50 of rabbit, male and female half and half, body weight 1.8~2.2kg is divided into 5 groups at random, 10 every group.Respectively organize tame rabbit ear arteria comitans nervi mediani blood sampling 2.7ml adding before the administration and fill 3.8% sodium citrate 0.3ml in advance in vitro; Getting 0.1ml blood plasma behind the centrifugal 10min of 1000rpm respectively adds in 5 long 10cm, the internal diameter 9mm test tube; And in every test tube, add the 0.1ml normal saline; Incubation 1min in 37 ℃ of water-baths adds 0.28%CaCl again in every test tube 20.1ml, put into water-bath behind the mixing and begin to clock, every behind the 1min at a distance from slowly tilt test tube 1 time of 10s, motionless (fibrin formations) time of liquid level during record inclination test tube, get 5 test tube fibrin formation time averages as calcium clotting times again.Respectively organize the rabbit gastric infusion subsequently, matched group is irritated the normal saline of stomach with volume; Sheet group of the present invention is gastric infusion 1.6,0.8,0.4g crude drug/kg respectively; With the thin gastric infusion 1.6g of XUEMINGMU PIAN crude drug/kg.Successive administration 7d, every day 1 time, each 15ml/kg.Once more from tame rabbit ear arteria comitans nervi mediani blood sampling 2.7ml, measure the multiple calcium clotting time of blood plasma behind the last administration 45min, obtain clotting time and shorten percentage rate [value before 100 * (being worth after value-administration before the administration)/administration].
Experimental result: see table 4
The influence of the multiple calcium clotting time of table 4 pair rabbit
Figure BSA00000581455000102
Compare * * P<0.01 with matched group; With with the XUEMINGMU PIAN group than △ P<0.05.
The result shows: sheet group of the present invention and have the effect of shortening the multiple calcium clotting time of rabbit with the XUEMINGMU PIAN group, compared utmost point significant difference (P<0.01) with matched group; The heavy dose of group of sheet of the present invention with and the XUEMINGMU PIAN group significant difference (P<0.05) of having compared.It is thus clear that the Blood clotting of sheet group ratio of the present invention and XUEMINGMU PIAN group is strong.
Five, to the phagocytotic influence of Turnover of Mouse Peritoneal Macrophages
Experiment material
1, animal: Kunming mouse, male and female have concurrently, body weight 18~22g.
2, medicine: with XUEMINGMU PIAN 0.84g crude drug/sheet; Large, medium and small three the dose groups 0.84g crude drug/sheets of sheet of the present invention.Medicine
Before experiment, dispose gastric infusion with distilled water.
Experimental technique
50 of Kunming mouses, male and female half and half, body weight 18~22g is divided into 5 groups at random, 10 every group.Matched group is irritated the normal saline of stomach with volume; Sheet group of the present invention is gastric infusion 3.6,1.8,0.9g crude drug/kg respectively; With XUEMINGMU PIAN group gastric infusion 3.6g crude drug/kg.Successive administration 7d, every day 1 time, lumbar injection 5% chicken red blood cell (CRBC) immediately after the last administration, every 0.5mL; Put to death mice behind the 4h, lumbar injection 0.9% sodium chloride injection, every 2mL gently rubs mouse web portion 1min; Draw the abdominal cavity drop on two slides, 37 ℃ of temperature are incubated 30min, and 0.9% sodium chloride solution rinsing is dried; Methanol is fixed, and the oily sem observation in back is dried in 4%Giemsa-Wright dyeing.Count 100 macrophages, calculate phagocytic index.(CRBC number/100 macrophage number * 100% that phagocytic index=quilt is engulfed)
Experimental result: see table 5
The phagocytotic influence of table 5 pair Turnover of Mouse Peritoneal Macrophages
Figure BSA00000581455000103
Figure BSA00000581455000111
Compare * * P<0.01 with matched group; With with the XUEMINGMU PIAN group than △ P<0.05.
The result shows: sheet group of the present invention and all possibly obviously improve the phagocytic index of Turnover of Mouse Peritoneal Macrophages with the XUEMINGMU PIAN group, compared utmost point significant difference (P<0.01) with matched group; The heavy dose of group of sheet of the present invention with and the XUEMINGMU PIAN group significant difference (P<0.05) of having compared.It is thus clear that the effect that sheet group ratio of the present invention and XUEMINGMU PIAN group promote blood stasis to absorb is strong.
Six, to the influence of mice capillary permeability
Experiment material
1, animal: Kunming mouse, male and female have concurrently, body weight 18~22g.
2, medicine: with XUEMINGMU PIAN 0.84g crude drug/sheet; Large, medium and small three the dose groups 0.84g crude drug/sheets of sheet of the present invention.Medicine disposes with distilled water before experiment, gastric infusion.
Experimental technique
50 of kunming mices, male and female half and half, body weight 18~22g is divided into 5 groups at random, 10 every group.Matched group is irritated the normal saline of stomach with volume; Sheet group of the present invention is gastric infusion 3.6,1.8,0.9g crude drug/kg respectively; With XUEMINGMU PIAN group gastric infusion 3.6g crude drug/kg.Successive administration 7d behind the last administration 1h, gives mouse tail vein injection 0.5% ivens blue 5ml/kg every day 1 time, and the 5min pneumoretroperitoneum is injected 0.5% acetic acid 10ml/kg.Take off vertebra behind the 30min and put to death, cut open the belly and use the distilled water flushing abdominal cavity, flushing liquor is diluted to 10ml, adds 0.1mol/L NaOH 0.1ml, places 30min.Divide spectrophotometer (590nm) colorimetric with 721 types.
Experimental result: see table 6
The influence of table 6 pair mice capillary permeability
Figure BSA00000581455000112
Figure BSA00000581455000113
Compare * * P<0.01 with matched group; With with the XUEMINGMU PIAN group than △ P<0.05.
The result shows: sheet group of the present invention and all significantly suppress the abdominal cavity capillary permeability with the XUEMINGMU PIAN group and increase; Improve capillary permeability; The antagonism nonspecific inflammation; Ooze out thereby suppress hemocyte effectively, help hemostasis, compare the difference (P<0.01) that utmost point significance is arranged with matched group; The heavy dose of group of sheet of the present invention with and the XUEMINGMU PIAN group significant difference (P<0.05) of having compared.It is thus clear that the effect of the inhibition capillary permeability of sheet ratio of the present invention and XUEMINGMU PIAN is strong.
Seven, to the microcirculatory influence of tame lagophthalmos conjunctiva
Experiment material
1, animal: rabbit, male and female have concurrently, body weight 1.8~2.2kg.
2, medicine: with XUEMINGMU PIAN 0.84g crude drug/sheet; Large, medium and small three the dose groups 0.84g crude drug/sheets of sheet of the present invention.Medicine disposes with distilled water before experiment, gastric infusion.
Experimental technique
Adopt tame lagophthalmos conjunctiva blood capillary fluorimetry.50 of rabbit, male and female half and half, body weight 1.8~2.2kg is divided into 5 groups at random, 10 every group.Matched group is irritated the normal saline of stomach with volume; Sheet group of the present invention is gastric infusion 1.6,0.8,0.4g crude drug/kg respectively; With XUEMINGMU PIAN group gastric infusion 1.6g crude drug/kg.Successive administration 7d, every day 1 time, each 15ml/kg, 1h after the last administration, the uranin normal saline solution 1ml/kg (being equivalent to fluorescein 100mg/kg) of ear vein injection 10%, the time of fluorescence appears in the record rabbit conjunctival.
Experimental result: see table 7
The table 7 pair microcirculatory influence of tame lagophthalmos conjunctiva
Figure BSA00000581455000121
Compare * * P<0.01 with matched group; With with the XUEMINGMU PIAN group than △ P<0.05.
The result shows: sheet group of the present invention and obviously quicken tame lagophthalmos conjunctiva microcirculation blood flow with the XUEMINGMU PIAN group, promote the eye microcirculation, and improve the ocular blood flow supply, compared utmost point significant difference (P<0.01) with matched group; The heavy dose of group of sheet of the present invention with and the XUEMINGMU PIAN group significant difference (P<0.05) of having compared.It is thus clear that the microcirculation improvement effect of sheet group ratio of the present invention and XUEMINGMU PIAN group is strong.
Eight, to effect of immunologic function
1, animal: Kunming mouse, male and female have concurrently, body weight 18~22g.
2, medicine: with XUEMINGMU PIAN 0.84g crude drug/sheet; Large, medium and small three the dose groups 0.84g crude drug/sheets of sheet of the present invention.Medicine disposes with distilled water before experiment, gastric infusion.
Experimental technique
50 of Kunming mouses, male and female half and half, body weight 18~22g is divided into 5 groups at random, 10 every group.Matched group is irritated the normal saline of stomach with volume; Sheet group of the present invention is gastric infusion 3.6,1.8,0.9g crude drug/kg respectively; With XUEMINGMU PIAN group gastric infusion 3.6g crude drug/kg.Successive administration 7d, every day 1 time, each 20ml/kg.Behind the administration 2d, each organizes the equal lumbar injection of mice 5: 3, and (V: V) the red born of the same parents' suspension of the sheep 0.2ml/ of dilution only carries out immunity.Continue administration 5d, behind the last administration 1h, pluck eyeball respectively and get blood, separation of serum, the content of mensuration hemolysin.
Experimental result: see table 8
Table 8 pair effect of immunologic function
Figure BSA00000581455000131
Figure BSA00000581455000132
Compare * * P<0.01 with matched group; With with the XUEMINGMU PIAN group than △ P<0.05.
The result shows: sheet group of the present invention and can obviously increase the content of hemolysin in the serum with the XUEMINGMU PIAN group, improve mouse humoral immune power, and compared utmost point significant difference (P<0.01) with matched group; The heavy dose of group of sheet of the present invention with and the XUEMINGMU PIAN group significant difference (P<0.05) of having compared.It is thus clear that it is strong that sheet group ratio of the present invention and XUEMINGMU PIAN group improve immunity function.
Conclusion: pharmacological actions such as the hemostasis of sheet ratio of the present invention and XUEMINGMU PIAN, blood coagulation, inhibition capillary permeability, microcirculation improvement, human body immunity improving power are strong; Therefore; Sheet group ratio of the present invention and XUEMINGMU PIAN are used for deficiency of YIN liver-yang hyperactivity, and the caused retinal hemorrhage clinical efficacy of thermal burn channels is good.
Toxicological experiment:
Acute toxicity testing is the result show: with tablet Cmax of the present invention, maximum volume gastric infusion, successive administration is 3 times in 24h, each 4h at interval, and accumulation medicine total amount reaches 38g crude drug/kg, is equivalent to 211.1 times of the clinical plan consumption of people.After the administration in the 7d, mice is movable, feed, drain all normal, well-grown, the hair color light, its average body weight average increases with the prolongation of test period.8d puts to death every mice perusal heart of back dissection, liver, spleen, lung, kidney, brain, thymus, stomach, intestinal etc. and does not all find color and paramophia, fails to measure LD 50Show that tablet of the present invention does not have acute toxic reaction.
Long term toxicity test is the result show: tablet ingredients of the present invention is that basic, normal, high dosage is respectively 4,8,16g crude drug/kg/d; Be equivalent to 22.2,44.4,88.9 times of clinical dosage; Gastric infusion is after 12 weeks; Tablet of the present invention does not all have tangible influence to general situation, hematological indices, the blood parameters of animal, the yet no abnormal pathological change of system's dissection, organ coefficient and histopathological examination.2 weeks of drug withdrawal are not seen obvious change yet.Tablet of the present invention is not found overt toxicity reaction and delayed toxicity reaction in long term toxicity test.It is thus clear that, tablet non-toxic reaction of the present invention, long-term prescription is safe and reliable.
The specific embodiment
1, the preparation of tablet of the present invention:
Prescription:
Figure BSA00000581455000141
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry; Be ground into fine powder, add dextrin, process granule with 85% ethanol, 60 ℃ of oven dry; Granulate adds magnesium stearate, mixing; Be pressed into 1000, coating promptly gets tablet.
2, the preparation of capsule of the present invention:
Prescription:
Figure BSA00000581455000142
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry; Be ground into fine powder, add starch, process granule with 85% ethanol, 60 ℃ of oven dry; Granulate, promptly gets capsule by encapsulated 1000.
3, the preparation of granule of the present invention:
Prescription:
Figure BSA00000581455000143
Figure BSA00000581455000151
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry; Be ground into fine powder, the adding dextrin is an amount of, processes granule with 85% ethanol, 60 ℃ of oven dry; Granulate makes granule 1000g, promptly gets granule.
4, the preparation of soft capsule of the present invention:
Prescription:
Figure BSA00000581455000152
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, and 60 ℃ of oven dry are ground into fine powder, gets the hybrid medicine fine powder, subsequent use; It is an amount of to get the adjuvant soybean oil, adds the Cera Flava of 4-6%, after heating makes dissolving, adds above-mentioned hybrid medicine fine powder, stirs, and colloid mill grinds well, and processes 1000 of soft capsules, promptly gets soft capsule.
5, the preparation of drop pill of the present invention:
Prescription:
Figure BSA00000581455000153
Method for preparing is:
More than 19 flavor medical materials, Flos Chrysanthemi, charcoal Radix Scutellariae, Semen Plantaginis (half amount), Pollen Typhae (half amount), mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; It is the thick paste of 1.35~1.39 (60 ℃) that filtrate decompression concentrates (0.08MPa, 80 ℃) to relative density, adds above-mentioned fine powder mix homogeneously, and 60 ℃ of oven dry are ground into fine powder, gets the hybrid medicine fine powder, subsequent use; Macrogol 4000 put in the water-bath heat, melt the back and add above-mentioned hybrid medicine fine powder, stirring is transferred to reservoir, airtight and in 70 ℃ of insulations, is coolant with the methyl-silicone oil, processes drop pill, promptly gets drop pill.

Claims (2)

1. method for preparing that is used for the Chinese medicine composition of cooling blood for hemostasis, YIN nourishing blood stasis dispelling, nourishing the liver to improve visual acuity; Said Chinese medicine composition is made up of Pollen Typhae 75g, Radix Salviae Miltiorrhizae 75g, Radix Rehmanniae 60g, Herba Ecliptae 60g, Flos Chrysanthemi 50g, charcoal Radix Scutellariae 45g, Semen Cassiae 45g, Semen Plantaginis 45g, Fructus Leonuri 45g, Fructus Ligustri Lucidi 45g, Spica Prunellae 45g, Radix Gentianae 45g, Radix Curcumae 30g, Herba Equiseti Hiemalis 45g, Radix Paeoniae Rubra 30g, Cortex Moutan 30g, Fructus Crataegi 30g, Radix Angelicae Sinensis 30g and Rhizoma Chuanxiong 10g; It is characterized in that method for preparing is: above 19 flavor medical materials; Flos Chrysanthemi, charcoal Radix Scutellariae, partly measure Semen Plantaginis, partly measure Pollen Typhae; Mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; Control vacuum was 80 ℃ for-0.08MPa, temperature when filtrate decompression concentrated; Relative density is 1.35~1.39 thick paste when being concentrated into temperature and being 60 ℃; Add above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry are ground into fine powder; Add each dosage form proper auxiliary materials, process tablet, capsule, granule or drop pill by each dosage form common process.
2. the method for preparing of Chinese medicine composition according to claim 1; Said Chinese medicine composition is made up of Pollen Typhae 75g, Radix Salviae Miltiorrhizae 75g, Radix Rehmanniae 60g, Herba Ecliptae 60g, Flos Chrysanthemi 50g, charcoal Radix Scutellariae 45g, Semen Cassiae 45g, Semen Plantaginis 45g, Fructus Leonuri 45g, Fructus Ligustri Lucidi 45g Spica Prunellae 45g, Radix Gentianae 45g, Radix Curcumae 30g, Herba Equiseti Hiemalis 45g, Radix Paeoniae Rubra 30g, Cortex Moutan 30g, Fructus Crataegi 30g, Radix Angelicae Sinensis 30g and Rhizoma Chuanxiong 10g; It is characterized in that method for preparing is: above 19 flavor medical materials; Flos Chrysanthemi, charcoal Radix Scutellariae, partly measure Semen Plantaginis, partly measure Pollen Typhae; Mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; Control vacuum was for-0.08MPa, temperature are 80 ℃ when filtrate decompression concentrated, and relative density is 1.35~1.39 thick paste when being concentrated into temperature and being 60 ℃, adds above-mentioned fine powder mix homogeneously, 60 ℃ of oven dry; Be ground into fine powder, add dextrin, process granule with 85% ethanol, 60 ℃ of oven dry; Granulate adds magnesium stearate, mixing; Be pressed into 1000, coating promptly gets tablet.
3. the method for preparing of Chinese medicine composition according to claim 1; Said Chinese medicine composition is made up of Pollen Typhae 75g, Radix Salviae Miltiorrhizae 75g, Radix Rehmanniae 60g, Herba Ecliptae 60g, Flos Chrysanthemi 50g, charcoal Radix Scutellariae 45g, Semen Cassiae 45g, Semen Plantaginis 45g, Fructus Leonuri 45g, Fructus Ligustri Lucidi 45g Spica Prunellae 45g, Radix Gentianae 45g, Radix Curcumae 30g, Herba Equiseti Hiemalis 45g, Radix Paeoniae Rubra 30g, Cortex Moutan 30g, Fructus Crataegi 30g, Radix Angelicae Sinensis 30g and Rhizoma Chuanxiong 10g; It is characterized in that method for preparing is: above 19 flavor medical materials; Flos Chrysanthemi, Radix Scutellariae, partly measure Semen Plantaginis, partly measure Pollen Typhae; Mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; Control vacuum was for-0.08MPa, temperature are 80 ℃ when filtrate decompression concentrated, and relative density is 1.35~1.39 thick paste when being concentrated into temperature and being 60 ℃, adds above-mentioned fine powder mix homogeneously; 60 ℃ of oven dry are ground into fine powder, add starch; Process granule with 85% ethanol, 60 ℃ of oven dry, granulate; Encapsulated 1000, promptly get capsule.
4. the method for preparing of Chinese medicine composition according to claim 1; Said Chinese medicine composition is made up of Pollen Typhae 75g, Radix Salviae Miltiorrhizae 75g, Radix Rehmanniae 60g, Herba Ecliptae 60g, Flos Chrysanthemi 50g, charcoal Radix Scutellariae 45g, Semen Cassiae 45g, Semen Plantaginis 45g, Fructus Leonuri 45g, Fructus Ligustri Lucidi 45g Spica Prunellae 45g, Radix Gentianae 45g, Radix Curcumae 30g, Herba Equiseti Hiemalis 45g, Radix Paeoniae Rubra 30g, Cortex Moutan 30g, Fructus Crataegi 30g, Radix Angelicae Sinensis 30g and Rhizoma Chuanxiong 10g; It is characterized in that method for preparing is: above 19 flavor medical materials; Flos Chrysanthemi, Radix Scutellariae, partly measure Semen Plantaginis, partly measure Pollen Typhae; Mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; Control vacuum was for-0.08MPa, temperature are 80 ℃ when filtrate decompression concentrated, and relative density is 1.35~1.39 thick paste when being concentrated into temperature and being 60 ℃, adds above-mentioned fine powder mix homogeneously; 60 ℃ of oven dry are ground into fine powder, and the adding dextrin is an amount of; Process granule with 85% ethanol, 60 ℃ of oven dry, granulate; Make granule 1000g, promptly get granule.
5. the method for preparing of Chinese medicine composition according to claim 1; Said Chinese medicine composition is made up of Pollen Typhae 75g, Radix Salviae Miltiorrhizae 75g, Radix Rehmanniae 60g, Herba Ecliptae 60g, Flos Chrysanthemi 50g, charcoal Radix Scutellariae 45g, Semen Cassiae 45g, Semen Plantaginis 45g, Fructus Leonuri 45g, Fructus Ligustri Lucidi 45g Spica Prunellae 45g, Radix Gentianae 45g, Radix Curcumae 30g, Herba Equiseti Hiemalis 45g, Radix Paeoniae Rubra 30g, Cortex Moutan 30g, Fructus Crataegi 30g, Radix Angelicae Sinensis 30g and Rhizoma Chuanxiong 10g; It is characterized in that method for preparing is: above 19 flavor medical materials; Flos Chrysanthemi, charcoal Radix Scutellariae, partly measure Semen Plantaginis, partly measure Pollen Typhae; Mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; Control vacuum was for-0.08MPa, temperature are 80 ℃ when filtrate decompression concentrated, and relative density is 1.35~1.39 thick paste when being concentrated into temperature and being 60 ℃, adds above-mentioned fine powder mix homogeneously, and 60 ℃ of oven dry are ground into fine powder, the hybrid medicine fine powder, subsequent use; It is an amount of to get the adjuvant soybean oil, adds the Cera Flava of 4-6%, after heating makes dissolving, adds above-mentioned hybrid medicine fine powder, stirs, and colloid mill grinds well, and processes 1000 of soft capsules, promptly gets soft capsule.
6. the method for preparing of Chinese medicine composition according to claim 1; Said Chinese medicine composition is made up of Pollen Typhae 75g, Radix Salviae Miltiorrhizae 75g, Radix Rehmanniae 60g, Herba Ecliptae 60g, Flos Chrysanthemi 50g, charcoal Radix Scutellariae 45g, Semen Cassiae 45g, Semen Plantaginis 45g, Fructus Leonuri 45g, Fructus Ligustri Lucidi 45g Spica Prunellae 45g, Radix Gentianae 45g, Radix Curcumae 30g, Herba Equiseti Hiemalis 45g, Radix Paeoniae Rubra 30g, Cortex Moutan 30g, Fructus Crataegi 30g, Radix Angelicae Sinensis 30g and Rhizoma Chuanxiong 10g; It is characterized in that method for preparing is: above 19 flavor medical materials; Flos Chrysanthemi, charcoal Radix Scutellariae, partly measure Semen Plantaginis, partly measure Pollen Typhae; Mixed powder is broken into fine powder, and is subsequent use; Residue Semen Plantaginis, Pollen Typhae and all the other each flavors add 60% soak with ethanol 30 minutes, the reflux, extract, secondary, and each 2 hours, add 6 times of amounts of 60% ethanol for the first time, add 6 times of amounts of 60% ethanol for the second time, merge extracted twice liquid, filter; Control vacuum was for-0.08MPa, temperature are 80 ℃ when filtrate decompression concentrated, and relative density is 1.35~1.39 thick paste when being concentrated into temperature and being 60 ℃, adds above-mentioned fine powder mix homogeneously, and 60 ℃ of oven dry are ground into fine powder, the hybrid medicine fine powder, subsequent use; Macrogol 4000 put in the water-bath heat, melt the back and add above-mentioned hybrid medicine fine powder, stirring is transferred to reservoir, airtight and in 70 ℃ of insulations, is coolant with the methyl-silicone oil, processes drop pill, promptly gets drop pill.
CN2011102887105A 2011-09-26 2011-09-26 Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof Active CN102319400B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102887105A CN102319400B (en) 2011-09-26 2011-09-26 Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102887105A CN102319400B (en) 2011-09-26 2011-09-26 Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof

Publications (2)

Publication Number Publication Date
CN102319400A CN102319400A (en) 2012-01-18
CN102319400B true CN102319400B (en) 2012-11-28

Family

ID=45447325

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102887105A Active CN102319400B (en) 2011-09-26 2011-09-26 Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102319400B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103207181A (en) * 2013-05-07 2013-07-17 西安碑林药业股份有限公司 Quality detection method for traditional Chinese medicinal preparation for treating fundus hemorrhage disease
CN106421650B (en) * 2016-10-26 2019-08-13 西安碑林药业股份有限公司 A kind of Chinese medicine composition treats the purposes in senile ocular fundus arteriosclerosis and fundus flavimaculatus lesion drug in preparation
CN107823442B (en) * 2017-11-17 2020-10-27 广州大学 Hemostatic and anti-infectious pharmaceutical composition
CN108815390A (en) * 2018-08-16 2018-11-16 贵州苗之源苗药中药饮片有限公司 A kind of Chinese medicine composition and preparation method thereof improving eyesight
CN108815389A (en) * 2018-08-16 2018-11-16 贵州苗之源苗药中药饮片有限公司 A kind of Chinese medicine composition to nourish the liver to improve visual acuity
CN114569661B (en) * 2020-11-30 2023-10-03 西安碑林药业股份有限公司 Preparation method of traditional Chinese medicine composition and traditional Chinese medicine composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1451422A (en) * 2003-05-21 2003-10-29 西安碑林药业股份有限公司 Chinese medicine for treating fundus oculi bleeding
CN1544074A (en) * 2003-05-21 2004-11-10 西安碑林药业股份有限公司 Chinese traditional medicine for treating optical fundus hemorrhage and its preparing process
CN101028487A (en) * 2007-04-04 2007-09-05 西安碑林药业股份有限公司 Chinese-medicinal preparation for treating eyeground bleeding and method for inspecting vision-improving prescription quality

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1451422A (en) * 2003-05-21 2003-10-29 西安碑林药业股份有限公司 Chinese medicine for treating fundus oculi bleeding
CN1544074A (en) * 2003-05-21 2004-11-10 西安碑林药业股份有限公司 Chinese traditional medicine for treating optical fundus hemorrhage and its preparing process
CN101028487A (en) * 2007-04-04 2007-09-05 西安碑林药业股份有限公司 Chinese-medicinal preparation for treating eyeground bleeding and method for inspecting vision-improving prescription quality

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
和血明目片方义及临床应用;王辉等;《湖南中医药大学学报》;20101231;第30卷(第12期);17-18 *
和血明目片联合香丹注射液治疗视网膜静脉阻塞的临床分析;张姝;《中国疗养医学》;20080530(第05期);314 *
张姝.和血明目片联合香丹注射液治疗视网膜静脉阻塞的临床分析.《中国疗养医学》.2008,(第05期),
王辉等.和血明目片方义及临床应用.《湖南中医药大学学报》.2010,第30卷(第12期),

Also Published As

Publication number Publication date
CN102319400A (en) 2012-01-18

Similar Documents

Publication Publication Date Title
CN102319400B (en) Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof
CN103520293B (en) Improve and treat the Chinese medicine for oral administration of constipation
CN102319398B (en) Blood-nourishing and eyesight-improving Chinese medicinal composition and preparation method thereof
CN102416106A (en) Chinese medicinal composition for treating middle-aged and senile eye disease and preparation method thereof
CN104983916B (en) There are health product of enhancing immunity and slow down aging and preparation method and application
CN102423420A (en) Traditional Chinese medicine combination for vision rehabilitation and preparation method thereof
CN1558768A (en) A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof
CN102526423A (en) Medicine composition for treating ischemic heart disease
CN104173503A (en) Preparation method of traditional Chinese medicine granules, traditional Chinese medicine granules prepared by same and use of traditional Chinese medicine granules
CN106535912B (en) Control pharmaceutical composition and its application of human body blood fat and body weight
CN110368445A (en) A kind of Chinese medicine composition and its preparation method and application for treating psoriasis
CN103006831B (en) Blood platelet raising capsules, namely Chinese herbal combination, and preparation method of capsules
CN103705860B (en) A kind of Chinese medicine composition for the treatment of infant jaundice and preparation method thereof
CN102293847B (en) Chinese medicinal composition for treating constipation, acne and hyperlipidemia, and preparation method
CN102078509B (en) Traditional Chinese medicine preparation for treating ophthalmorrhagia and preparation method thereof
CN103566227B (en) A kind of Chinese medicine composition preventing and treating type 2 diabetes mellitus and preparation method thereof
CN1939383B (en) Use of redback christmashush in preparing medicine for hepatitis B
CN110339252B (en) Traditional Chinese medicine composition for relieving non-alcoholic steatohepatitis and preparation method and product thereof
CN105727089A (en) Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome
CN103006832B (en) Chinese herbal combination for raising blood platelets and preparation method of combination
CN1331465C (en) Blood stasis dispelling dripping pills for treating coronary heart disease, angina pectoris and hyperlipemia and preparation process thereof
CN101406576B (en) Chinese medicine for treating diabetes and preparation method
CN104784354B (en) A kind of Chinese medicine acupoint injection therapy liquid and its preparation method treating migraine
CN104161849B (en) A kind of Chinese medicinal tablet treating diabetic retinopathy and application thereof
CN102018940B (en) Composition with lactogenic effect and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof

Effective date of registration: 20151130

Granted publication date: 20121128

Pledgee: The Bank of Xi'an branch of Limited by Share Ltd

Pledgor: Beilin Pharmaceutical Co., Ltd., Xi'an

Registration number: 2015990001065

PLDC Enforcement, change and cancellation of contracts on pledge of patent right or utility model
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20161207

Granted publication date: 20121128

Pledgee: The Bank of Xi'an branch of Limited by Share Ltd

Pledgor: Beilin Pharmaceutical Co., Ltd., Xi'an

Registration number: 2015990001065

PLDC Enforcement, change and cancellation of contracts on pledge of patent right or utility model